Barclays’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$836K Buy
317,877
+98,673
+45% +$232K ﹤0.01% 2859
2025
Q4
$419K Buy
219,204
+176,142
+409% +$417K ﹤0.01% 3939
2025
Q3
$95.6K Sell
43,062
-2,761
-6% -$6.63K ﹤0.01% 4629
2025
Q2
$65.5K Sell
45,823
-61,697
-57% -$89.7K ﹤0.01% 4662
2025
Q1
$172K Sell
107,520
-14,845
-12% -$44.3K ﹤0.01% 4136
2024
Q4
$441K Sell
122,365
-121,092
-50% -$602K ﹤0.01% 3899
2024
Q3
$1.39M Buy
243,457
+67,546
+38% +$406K ﹤0.01% 3132
2024
Q2
$813K Buy
175,911
+122,818
+231% +$732K ﹤0.01% 2727
2024
Q1
$434K Buy
53,093
+9,478
+22% +$73.5K ﹤0.01% 3678
2023
Q4
$246K Buy
43,615
+1
+0% +$2 ﹤0.01% 4328
2023
Q3
$81.1K Buy
43,614
+10,246
+31% +$31.3K ﹤0.01% 3674
2023
Q2
$91.8K Sell
33,368
-13,995
-30% -$45K ﹤0.01% 3596
2023
Q1
$149K Sell
47,363
-56,285
-54% -$331K ﹤0.01% 3963
2022
Q4
$612K Buy
103,648
+28,408
+38% +$236K ﹤0.01% 3176
2022
Q3
$660K Buy
75,240
+71,244
+1,783% +$740K ﹤0.01% 2514
2022
Q2
$30K Sell
3,996
-23,647
-86% -$208K ﹤0.01% 4242
2022
Q1
$670K Buy
+27,643
New +$671K ﹤0.01% 2695

Other funds holding CCCC